Cargando…
Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS
BACKGROUND: Moyamoya disease (MMD) is an uncommon cerebrovascular condition with unknown etiology characterized by slowly progressive stenosis or occlusion of the bilateral internal carotid arteries associated with an abnormal vascular network. MMD is a major cause of stroke, specifically in the you...
Autores principales: | Araki, Yoshio, Yoshikawa, Kazuhiro, Okamoto, Sho, Sumitomo, Masaki, Maruwaka, Mikio, Wakabayashi, Toshihiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992492/ https://www.ncbi.nlm.nih.gov/pubmed/21059247 http://dx.doi.org/10.1186/1471-2377-10-112 |
Ejemplares similares
-
The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
por: Liu, Chibo
Publicado: (2011) -
SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma
por: Huang, Yuan-Jiao, et al.
Publicado: (2009) -
Research progress in SELDI-TOF MS and its clinical applications
por: CHO, William Chi-Shing
Publicado: (2006) -
Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS
por: De Bock, Muriel, et al.
Publicado: (2010) -
Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS
por: Campostrini, Natascia, et al.
Publicado: (2010)